Copyright © 2008 Panayoula C. Tsiotra et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

1. C. M. Steppan, S. T. Bailey, S. Bhat, et al., “The hormone resistin links obesity to diabetes,” Nature, vol. 409, no. 6818, pp. 307–312, 2001. View at Publisher · View at Google Scholar · View at PubMed
2. H. Tilg and A. R. Moschen, “Adipocytokines: mediators linking adipose tissue, inflammation and immunity,” Nature Reviews Immunology, vol. 6, no. 10, pp. 772–783, 2006. View at Publisher · View at Google Scholar · View at PubMed
3. J. N. Fain, “Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity and primarily due to the nonfat cells,” Vitamins & Hormones, vol. 74, pp. 443–477, 2006. View at Publisher · View at Google Scholar · View at PubMed
4. A. Bouloumié, C. A. Curat, C. Sengenès, K. Lolmède, A. Miranville, and R. Busse, “Role of macrophage tissue infiltration in metabolic diseases,” Current Opinion in Clinical Nutrition and Metabolic Care, vol. 8, no. 4, pp. 347–354, 2005.
5. K. E. Wellen and G. S. Hotamisligil, “Inflammation, stress, and diabetes,” Journal of Clinical Investigation, vol. 115, no. 5, pp. 1111–1119, 2005. View at Publisher · View at Google Scholar
6. S. P. Weisberg, D. McCann, M. Desai, M. Rosenbaum, R. L. Leibel, and A. W. Ferrante Jr., “Obesity is associated with macrophage accumulation in adipose tissue,” Journal of Clinical Investigation, vol. 112, no. 12, pp. 1796–1808, 2003. View at Publisher · View at Google Scholar · View at PubMed
7. C. A. Curat, V. Wegner, C. Sengenès, et al., “Macrophages in human visceral adipose tissue: increased accumulation in obesity and a source of resistin and visfatin,” Diabetologia, vol. 49, no. 4, pp. 744–747, 2006. View at Publisher · View at Google Scholar · View at PubMed
8. I. N. Holcomb, R. C. Kabakoff, B. Chan, et al., “FIZZ1, a novel cysteine-rich secreted protein associated with pulmonary inflammation, defines a new gene family,” The EMBO Journal, vol. 19, no. 15, pp. 4046–4055, 2000. View at Publisher · View at Google Scholar · View at PubMed
9. M. Lehrke, M. P. Reilly, S. C. Millington, N. Iqbal, D. J. Rader, and M. A. Lazar, “An inflammatory cascade leading to hyperresistinemia in humans,” PLoS Medicine, vol. 1, pp. 161–168, 2004. View at Publisher · View at Google Scholar · View at PubMed
10. P. D. Anderson, N. N. Mehta, M. L. Wolfe, et al., “Innate immunity modulates adipokines in humans,” The Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 6, pp. 2272–2279, 2007. View at Publisher · View at Google Scholar · View at PubMed
11. M. Bokarewa, I. Nagaev, L. Dahlberg, U. Smith, and A. Tarkowski, “Resistin, an adipokine with potent proinflammatory properties,” The Journal of Immunology, vol. 174, no. 9, pp. 5789–5795, 2005.
12. M. Bajaj, S. Suraamornkul, L. J. Hardies, T. Pratipanawatr, and R. A. DeFronzo, “Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients,” International Journal of Obesity, vol. 28, no. 6, pp. 783–789, 2004. View at Publisher · View at Google Scholar · View at PubMed
13. M. von Eynatten, J. G. Schneider, S. Hadziselimovic, et al., “Adipocytokines as a novel target for the anti-inflammatory effect of atorvastatin in patients with type 2 diabetes,” Diabetes Care, vol. 28, no. 3, pp. 754–755, 2005. View at Publisher · View at Google Scholar
14. N. Silswal, A. K. Singh, B. Aruna, S. Mukhopadhyay, S. Ghosh, and N. Z. Ehtesham, “Human resistin stimulates the pro-inflammatory cytokines TNF-$\alpha$ and IL-12 in macrophages by NF-$\kappa$B-dependent pathway,” Biochemical and Biophysical Research Communications, vol. 334, no. 4, pp. 1092–1101, 2005. View at Publisher · View at Google Scholar · View at PubMed
15. C. Rae and A. Graham, “Human resistin promotes macrophage lipid accumulation,” Diabetologia, vol. 49, no. 5, pp. 1112–1114, 2006. View at Publisher · View at Google Scholar · View at PubMed
16. D. Kawanami, K. Maemura, N. Takeda, et al., “Direct reciprocal effects of resistin and adiponectin on vascular endothelial cells: a new insight into adipocytokine-endothelial cell interactions,” Biochemical and Biophysical Research Communications, vol. 314, no. 2, pp. 415–419, 2004. View at Publisher · View at Google Scholar
17. H. S. Jung, K.-H. Park, Y. M. Cho, et al., “Resistin is secreted from macrophages in atheromas and promotes atherosclerosis,” Cardiovascular Research, vol. 69, no. 1, pp. 76–85, 2006. View at Publisher · View at Google Scholar · View at PubMed
18. M. P. Reilly, M. Lehrke, M. L. Wolfe, A. Rohatgi, M. A. Lazar, and D. J. Rader, “Resistin is an inflammatory marker of atherosclerosis in humans,” Circulation, vol. 111, no. 7, pp. 932–939, 2005. View at Publisher · View at Google Scholar · View at PubMed
19. M. S. Burnett, J. M. Devaney, R. J. Adenika, R. Lindsay, and B. V. Howard, “Cross-sectional associations of resistin, coronary heart disease, and insulin resistance,” The Journal of Clinical Endocrinology & Metabolism, vol. 91, no. 1, pp. 64–68, 2006. View at Publisher · View at Google Scholar · View at PubMed
20. V. Beauloye, F. Zech, H. T. T. Mong, P. Clapuyt, M. Maes, and S. M. Brichard, “Determinants of early atherosclerosis in obese children and adolescents,” The Journal of Clinical Endocrinology & Metabolism, vol. 92, no. 8, pp. 3025–3032, 2007. View at Publisher · View at Google Scholar · View at PubMed
21. L. Patel, A. C. Buckels, I. J. Kinghorn, et al., “Resistin is expressed in human macrophages and directly regulated by PPAR$\gamma$ activators,” Biochemical and Biophysical Research Communications, vol. 300, no. 2, pp. 472–476, 2003. View at Publisher · View at Google Scholar
22. M. W. Rajala, S. Obici, P. E. Scherer, and L. Rossetti, “Adipose-derived resistin and gut-derived resistin-like molecule-$\beta$ selectively impair insulin action on glucose production,” Journal of Clinical Investigation, vol. 111, no. 2, pp. 225–230, 2003. View at Publisher · View at Google Scholar
23. R. R. Banerjee, S. M. Rangwala, J. S. Shapiro, et al., “Regulation of fasted blood glucose by resistin,” Science, vol. 303, no. 5661, pp. 1195–1198, 2004. View at Publisher · View at Google Scholar · View at PubMed
24. J. Janke, S. Engeli, K. Gorzelniak, F. C. Luft, and A. M. Sharma, “Resistin gene expression in human adipocytes is not related to insulin resistance,” Obesity Research, vol. 10, no. 1, pp. 1–5, 2002. View at Publisher · View at Google Scholar · View at PubMed
25. J. H. Lee, J. L. Chan, N. Yiannakouris, et al., “Circulating resistin levels are not associated with obesity or insulin resistance in humans and are not regulated by fasting or leptin administration: cross-sectional and interventional studies in normal, insulin-resistant, and diabetic subjects,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 10, pp. 4848–4856, 2003. View at Publisher · View at Google Scholar
26. K. M. Utzschneider, D. B. Carr, J. Tong, et al., “Resistin is not associated with insulin sensitivity or the metabolic syndrome in humans,” Diabetologia, vol. 48, no. 11, pp. 2330–2333, 2005. View at Publisher · View at Google Scholar · View at PubMed
27. M. Degawa-Yamauchi, J. E. Bovenkerk, B. E. Juliar, et al., “Serum resistin (FIZZ3) protein is increased in obese humans,” The Journal of Clinical Endocrinology & Metabolism, vol. 88, no. 11, pp. 5452–5455, 2003. View at Publisher · View at Google Scholar
28. B.-S. Youn, K.-Y. Yu, H. J. Park, et al., “Plasma resistin concentrations measured by enzyme-linked immunosorbent assay using a newly developed monoclonal antibody are elevated in individuals with type 2 diabetes mellitus,” The Journal of Clinical Endocrinology & Metabolism, vol. 89, no. 1, pp. 150–156, 2004. View at Publisher · View at Google Scholar
29. Y. Tokuyama, H. Osawa, T. Ishizuka, et al., “Serum resistin level is associated with insulin sensitivity in Japanese patients with type 2 diabetes mellitus,” Metabolism, vol. 56, no. 5, pp. 693–698, 2007. View at Publisher · View at Google Scholar · View at PubMed
30. P. C. Tsiotra, C. Tsigos, E. Yfanti, et al., “Visfatin, TNF-$\alpha$ and IL-6 mRNA expression is increased in mononuclear cells from type 2 diabetic women,” Hormone and Metabolic Research, vol. 39, no. 10, pp. 758–763, 2007. View at Publisher · View at Google Scholar · View at PubMed
31. P. C. Tsiotra, C. Tsigos, C. Gatsiou, and S. A. Raptis, “Effects of glucose, insulin and leptin on resistin mRNA and protein production from human peripheral monocytes,” International Journal Obesity, vol. 28, supplement 1, p. S130, 2004.
32. J. Kawashima, K. Tsuruzoe, H. Motoshima, et al., “Insulin down-regulates resistin mRNA through the synthesis of protein(s) that could accelerate the degradation of resistin mRNA in 3T3-L1 adipocytes,” Diabetologia, vol. 46, no. 2, pp. 231–240, 2003.
33. E. Krušinová, M. Klementová, J. Kopecký, et al., “Effect of acute hyperinsulinaemia with and without angiotensin II type 1 receptor blockade on resistin and adiponectin concentrations and expressions in healthy subjects,” European Journal of Endocrinology, vol. 157, no. 4, pp. 443–449, 2007. View at Publisher · View at Google Scholar · View at PubMed
34. E. Maury, K. Ehala-Aleksejev, Y. Guiot, R. Detry, A. Vandenhooft, and S. M. Brichard, “Adipokines oversecreted by omental adipose tissue in human obesity,” American Journal of Physiology, vol. 293, no. 3, pp. E656–E665, 2007. View at Publisher · View at Google Scholar · View at PubMed
35. P. Arner, “Resistin: yet another adipokine tells us that men are not mice,” Diabetologia, vol. 48, no. 11, pp. 2203–2205, 2005. View at Publisher · View at Google Scholar · View at PubMed
36. H.-L. Lu, H.-W. Wang, Y. Wen, M.-X. Zhang, and H.-H. Lin, “Roles of adipocyte derived hormone adiponectin and resistin in insulin resistance of type 2 diabetes,” World Journal of Gastroenterology, vol. 12, no. 11, pp. 1747–1751, 2006.
37. J. Spranger, A. Kroke, M. Möhlig, et al., “Inflammatory cytokines and the risk to develop type 2 diabetes: results of the prospective population-based European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam study,” Diabetes, vol. 52, no. 3, pp. 812–817, 2003. View at Publisher · View at Google Scholar
38. E. Ruotsalainen, U. Salmenniemi, I. Vauhkonen, et al., “Changes in inflammatory cytokines are related to impaired glucose tolerance in offspring of type 2 diabetic subjects,” Diabetes Care, vol. 29, no. 12, pp. 2714–2720, 2006. View at Publisher · View at Google Scholar · View at PubMed
39. A. L. Carey, C. R. Bruce, M. Sacchetti, et al., “Interleukin-6 and tumor necrosis factor-$\alpha$ are not increased in patients with type 2 diabetes: evidence that plasma interleukin-6 is related to fat mass and not insulin responsiveness,” Diabetologia, vol. 47, no. 6, pp. 1029–1037, 2004. View at Publisher · View at Google Scholar · View at PubMed
40. P. Dandona, A. Aljada, and A. Bandyopadhyay, “Inflammation: the link between insulin resistance, obesity and diabetes,” Trends in Immunology, vol. 25, no. 1, pp. 4–7, 2004. View at Publisher · View at Google Scholar
41. R. Cancello and K. Clément, “Is obesity an inflammatory illness? Role of low-grade inflammation and macrophage infiltration in human white adipose tissue,” BJOG, vol. 113, no. 10, pp. 1141–1147, 2006. View at Publisher · View at Google Scholar · View at PubMed